Food Sensitivities, Food Allergies, and Food Intolerances: The Clinical Distinction That Matters

True food allergy is an immune-mediated adverse reaction to a specific food protein, driven by immunoglobulin E (IgE) antibodies. The initial exposure triggers allergen-specific IgE production by B lymphocytes; these IgE molecules bind to high-affinity receptors on mast cells and basophils. On subsequent exposures, the allergen crosslinks these cell-surface IgE molecules, triggering mast cell degranulation and the rapid release of histamine, prostaglandins, leukotrienes, and other mediators. The clinical consequence ranges from mild urticaria to life-threatening anaphylaxis.[1]

IgE-mediated food allergy affects approximately 6–8% of children and 2–4% of adults in Western countries.[2] The “Big Nine” recognized by U.S. labeling law are milk, egg, peanut, tree nuts, wheat, soy, fish, shellfish, and sesame. Peanut and tree nut allergies are of particular concern due to their association with severe anaphylaxis and their persistence into adulthood; milk and egg allergies commonly resolve during childhood.

Food intolerance refers to adverse reactions to foods that are not immune-mediated. They are driven by enzymatic deficiencies, pharmacologic effects of food constituents, malabsorption of specific carbohydrates, or direct mucosal effects. The clinical manifestations are predominantly gastrointestinal — bloating, flatulence, diarrhea, abdominal cramping. Systemic reactions, urticaria, and anaphylaxis do not occur.

IgG-based food “sensitivity” panels measure serum IgG antibodies to panels of 90–200+ food antigens and report elevated titers as evidence of “food sensitivities” requiring dietary elimination. These panels are commercially successful and widely marketed.

The scientific problem: IgG antibodies — particularly IgG4, which these panels predominantly measure — are a normal immunological response to dietary antigen exposure. Elevated food-specific IgG4 represents immunological tolerance, not reactivity. It is the expected finding after regular consumption of a food, and IgG4 titers are higher for foods consumed frequently.

The European Academy of Allergy and Clinical Immunology (EAACI) position paper explicitly states: “IgG4 does not trigger clinical symptoms upon exposure to food antigens” and that “testing for IgG4 antibodies against foods is not recommended as a diagnostic tool for food allergy or intolerance.”[9] This position is shared by the AAAAI, CSACI, and every major allergy and immunology body that has reviewed the evidence.[10]

Clinical consequences of IgG testing are not benign: nutritional inadequacy from broad dietary elimination without clinical justification; unnecessary food fear and disordered eating patterns; financial cost; delay in correct diagnosis of conditions with evidence-based management; and erosion of trust in evidence-based medicine when the “diagnosis” does not hold up clinically.

Food allergy, food intolerance, and food sensitivity are distinct phenomena with distinct mechanisms, distinct diagnostic approaches, and distinct clinical significance. Conflating them — or worse, replacing validated diagnostic methods with IgG-based panels that have no evidentiary basis — produces worse clinical outcomes, unnecessary dietary restriction, nutritional harm, and significant financial cost to patients.

“Precision medicine demands precision diagnostics. That standard must apply to the evaluation of adverse food reactions with the same rigor applied to every other clinical domain.”